General
Biotech giant to slash 3000 jobs, spin-off vaccine arm
Australian pharmaceutical giant CSL will cut as many as 3000 jobs and spin-off its flu vaccine arm into a separate business in a bid to shave $500 million from its bottom line.
The…
Continue Reading
-
General24 hours agoPlan to convert Sydney golf course into cemetery ‘short-sighted’ as consultation set to start
-
Noosa News14 hours agoTop chefs rally for Noosa Reds farmers Pete and Dory
-
Business12 hours agoThis ASX healthcare stock could be a buy low bargain
-
General17 hours agoDonald Trump and Volodymyr Zelenskyy meet at White House for Ukraine peace talks